|
1
|
Cheung G, Sahai A, Billia M, Dasgupta P
and Khan MS: Recent advances in the diagnosis and treatment of
bladder cancer. BMC Med. 11:132013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Fedewa SA, Miller KD,
Goding-Sauer A, Pinheiro PS, Martinez-Tyson D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2015. CA Cancer J Clin.
65:457–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu MC, Skipper PL, Tannenbaum SR, Chan KK
and Ross RK: Arylamine exposures and bladder cancer risk. Mutat Res
506-507. 1–28. 2002.
|
|
4
|
Letašiová S, Dušinská M, Volkovová K,
Mosoiu C and Bartonva A: Bladder cancer, a review of the
environmental risk factors. Environ Health. 11 Suppl 1:S112012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao L, Geng H, Liang ZF, Zhang ZQ, Zhang
T, Yu DX and Zhong CY: Benzidine induces epithelial-mesenchymal
transition in human uroepithelial cells through ERK1/2 pathway.
Biochem Biophys Res Commun. 459:643–649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Correia I, Alonso-Monge R and Pla J: MAPK
cell-cycle regulation in Saccharomyces cerevisiae and Candida
albicans. Future Microbiol. 5:1125–1141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thomasova D and Anders HJ: Cell cycle
control in the kidney. Nephrol Dial Transplant. 30:1622–1630. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang LF and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sangrar W, Shi C, Mullins G, LeBrun D,
Ingalls B and Greer PA: Amplified Ras-MAPK signal states correlate
with accelerated EGFR internalization, cytostasis and delayed HER2
tumor onset in Fer-deficient model systems. Oncogene. 34:4109–4117.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dhanasekaran DN and Johnson GL: MAPKs:
Function, regulation, role in cancer and therapeutic targeting.
Oncogene. 26:3097–3099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ansari KM and Das M: Skin tumor promotion
by argemone oil/alkaloid in mice: Evidence for enhanced cell
proliferation, ornithine decarboxylase, cyclooxygenase-2 and
activation of MAPK/NF-kappaB pathway. Food Chem Toxicol.
48:132–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu T, Zhou M, Peng L, Kong S, Miao R, Shi
Y, Sheng H and Li L: Upregulation of CD147 promotes cell invasion,
epithelial-to-mesenchymal transition and activates MAPK/ERK
signaling pathway in colorectal cancer. Int J Clin Exp Pathol.
7:7432–7441. 2014.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baldi A, De Luca A, Esposito V, Campioni
M, Spugnini EP and Citro G: Tumor suppressors and cell-cycle
proteins in lung cancer. Pathol Res Int. 2011:6050422011.
View Article : Google Scholar
|
|
15
|
Sobus SL and Warren GW: The biologic
effects of cigarette smoke on cancer cells. Cancer. 120:3617–3626.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Gong X, Chen J, Zhang J, Sun J and
Guo M: miR-340 inhibits glioblastoma cell proliferation by
suppressing CDK6, cyclin-D1 and cyclin-D2. Biochem Biophys Res
Commun. 460:670–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y, Luo D and Liao DJ: CyclinD1 protein
plays different roles in modulating chemoresponses in MCF7 and
MDA-MB231 cells. J Carcinog. 11:122012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo ZY, Hao XH, Tan FF, Pei X, Shang LM,
Jiang XL and Yang F: The elements of human cyclin D1 promoter and
regulation involved. Clin Epigenetics. 2:63–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malmström PU, Wester K, Vasko J and Busch
C: Expression of proliferative cell nuclear antigen (PCNA) in
urinary bladder carcinoma. Evaluation of antigen retrieval methods.
APMIS. 100:988–992. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Russo G, Zamparelli A, Howard CM, Minimo
C, Bellan C, Carillo G, Califano L, Leoncini L, Giordano A and
Claudio PP: Expression of cell cycle-regulated proteins pRB2/p130,
p107, E2F4, p27, and pCNA in salivary gland tumors: Prognostic and
diagnostic implications. Clin Cancer Res. 11:3265–3273. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waga S, Hannon GJ, Beach D and Stillman B:
The p21 inhibitor of cyclin-dependent kinases controls DNA
replication by interaction with PCNA. Nature. 369:574–578. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shariat SF, Kim J, Raptidis G, Ayala GE
and Lerner SP: Association of p53 and p21 expression with clinical
outcome in patients with carcinoma in situ of the urinary bladder.
Urology. 61:1140–1145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang
F, Bai JW, Qiu SQ, Du CW, Huang WH and Zhang GJ: Over-expressed
twist associates with markers of epithelial mesenchymal transition
and predicts poor prognosis in breast cancers via ERK and Akt
activation. PloS One. 10:e01358512015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li T, Zhang C, Ding Y, Zhai W, Liu K, Bu
F, Tu T, Sun L, Zhu W, Zhou F, et al: Umbilical cord-derived
mesenchymal stem cells promote proliferation and migration in MCF-7
and MDA-MB-231 breast cancer cells through activation of the ERK
pathway. Oncol Rep. 34:1469–1477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han C and Wan F: Research progress on
AP-1. Chin J Cell Biol. 2017.
|
|
26
|
Schiefer AI, Vesely P, Hassler MR, Egger G
and Kenner L: The role of AP-1 and epigenetics in ALCL. Front
Biosci (Schol Ed). 7:226–235. 2015. View
Article : Google Scholar : PubMed/NCBI
|
